LORA BEBERMEYER: Open Payments
NPI 1528750932 · ELLSWORTH, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$645 in 30 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,790 · 2025 $645
Food & beverage: $645
| Company | Payments | Amount |
|---|---|---|
| Organogenesis Inc. | 9 | $281 |
| PFIZER INC. | 5 | $83 |
| ABBVIE INC. | 3 | $50 |
| Novo Nordisk Inc | 3 | $44 |
| BioWound Solutions, Inc. | 1 | $40 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Exact Sciences Corporation | 1 | $16 |
| Reprise Biomedical, Inc. | 1 | $16 |
Products named: PURAPLY WOUND MATRIX, AFFINITY, NURTEC ODT, VRAYLAR, APLIGRAF, bio-ConneKt, LEQVIO, GEMTESA.
Industry payments across KS — which companies pay providers there.
